Ascendis submits FDA application to start cancer trial

A year and a half after announcing its strategy for entering the cancer area, Ascendis Pharma is now preparing to start clinical trials with its first drug candidate.
Photo: Kevin Grønnemann / MedWatch
Photo: Kevin Grønnemann / MedWatch
BY MIKKEL AABENHUS HEMMINGSEN, TRANSLATED BY NIELSINE NIELSEN

Just before the new year, the biotech company Ascendis Pharma applied to the US Food and Drug Administration for permission to start running trials with a drug candidate for the treatment of cancer, according a company announcement.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading